Journal
REPRODUCTIVE BIOMEDICINE ONLINE
Volume 29, Issue 5, Pages 644-646Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.rbmo.2014.07.009
Keywords
liraglutide; male infertility; male reproduction; spermatozoa
Categories
Funding
- FAPERJ (Foundation of Research's Support of Rio de Janeiro) Rio de Janeiro, Brazil
- CNPQ (National Counsel of Technological and Scientific Development) Federal District, Brazil
Ask authors/readers for more resources
Liraglutide is an agonist of the glucagon-like peptide I receptor, and is commonly recommended as a treatment for obesity and type 2 diabetes mellitus. Adverse effects related to liraglutide include acute pancreatitis and polyarthritis. No studies, however, have reported an adverse effect of liraglutide on male reproduction. This case report shows a deleterious effect of liraglutide on male reproductive function. (C) 2014 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
